• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

作者信息

Vahanian Alec, Alfieri Ottavio, Andreotti Felicita, Antunes Manuel J, Barón-Esquivias Gonzalo, Baumgartner Helmut, Borger Michael Andrew, Carrel Thierry P, De Bonis Michele, Evangelista Arturo, Falk Volkmar, Lung Bernard, Lancellotti Patrizio, Pierard Luc, Price Susanna, Schäfers Hans-Joachim, Schuler Gerhard, Stepinska Janina, Swedberg Karl, Takkenberg Johanna, Von Oppell Ulrich Otto, Windecker Stephan, Zamorano Jose Luis, Zembala Marian

出版信息

Eur J Cardiothorac Surg. 2012 Oct;42(4):S1-44. doi: 10.1093/ejcts/ezs455. Epub 2012 Aug 25.

DOI:10.1093/ejcts/ezs455
PMID:22922698
Abstract
摘要

相似文献

1
Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).《心脏瓣膜病管理指南（2012年版）》：欧洲心脏病学会（ESC）和欧洲心胸外科学会（EACTS）心脏瓣膜病管理联合工作组
Eur J Cardiothorac Surg. 2012 Oct;42(4):S1-44. doi: 10.1093/ejcts/ezs455. Epub 2012 Aug 25.
2
Clinical approach and management of acquired valvular heart disease.获得性瓣膜性心脏病的临床处理与管理
Cardiovasc Clin. 1980;10(3):125-59.
3
Valvular Heart Disease.心脏瓣膜病
Prim Care. 2018 Mar;45(1):81-94. doi: 10.1016/j.pop.2017.10.002. Epub 2017 Dec 27.
4
[Heart defects in ambulatory practice].[门诊实践中的心脏缺陷]
Sov Med. 1990(11):29-33.
5
Recommendations on the management of the asymptomatic patient with valvular heart disease.无症状瓣膜性心脏病患者的管理建议。
Eur Heart J. 2002 Aug;23(16):1253-66. doi: 10.1053/euhj.2002.3320.
6
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏协会/美国心脏病学会瓣膜性心脏病患者管理指南：美国心脏病学会/美国心脏协会实践指南工作组报告
J Thorac Cardiovasc Surg. 2014 Jul;148(1):e1-e132. doi: 10.1016/j.jtcvs.2014.05.014. Epub 2014 May 9.
7
Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force II: Acquired valvular heart disease.运动员的心血管异常：关于参赛资格的建议。第二工作组：获得性瓣膜性心脏病
J Am Coll Cardiol. 1985 Dec;6(6):1209-14. doi: 10.1016/s0735-1097(85)80202-3.
8
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。特别工作组2：获得性瓣膜性心脏病。
J Am Coll Cardiol. 1994 Oct;24(4):874-80. doi: 10.1016/0735-1097(94)90843-5.
9
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。特别工作组2：后天性心脏瓣膜病。
Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S254-60.
10
Recognition and management of emergencies in valvular heart disease.心脏瓣膜病急症的识别与处理
Med Clin North Am. 1979 Jan;63(1):155-72. doi: 10.1016/s0025-7125(16)31722-9.

引用本文的文献

1
Comparison of Surgical Treatment Outcomes in Patients with Symptomatic Severe Aortic Valve Stenosis Using the Perceval Sutureless Bioprosthesis Versus a Conventional Biological Valve.使用Perceval无缝合生物瓣膜与传统生物瓣膜治疗有症状重度主动脉瓣狭窄患者的手术治疗结果比较
J Cardiovasc Dev Dis. 2025 Aug 13;12(8):308. doi: 10.3390/jcdd12080308.
2
Comparison of safety and efficacy in venous access closure using a double purse string suture technique vs. Z-suture technique after MitraClip procedure.MitraClip手术后使用双荷包缝合技术与Z形缝合技术进行静脉通路闭合的安全性和有效性比较。
Front Cardiovasc Med. 2025 Jul 25;12:1585522. doi: 10.3389/fcvm.2025.1585522. eCollection 2025.
3
Impact of Transcatheter Aortic Valve Implantation (TAVI) on Left Ventricular Mass, Volumes, and Pressure. A Single-center Echocardiographic Analysis.
经导管主动脉瓣植入术（TAVI）对左心室质量、容积和压力的影响：单中心超声心动图分析
J Saudi Heart Assoc. 2025 May 18;37(2):12. doi: 10.37616/2212-5043.1435. eCollection 2025.
4
Does Body Mass Index Impact Outcomes in Patients Undergoing Minimally Invasive Mitral Valve Surgery?体重指数对接受微创二尖瓣手术患者的预后有影响吗？
Medicina (Kaunas). 2025 May 16;61(5):903. doi: 10.3390/medicina61050903.
5
Nonlinear association between serum albumin levels and all-cause mortality in elderly patients with chronic aortic regurgitation.老年慢性主动脉瓣关闭不全患者血清白蛋白水平与全因死亡率之间的非线性关联。
J Geriatr Cardiol. 2025 Apr 28;22(4):423-432. doi: 10.26599/1671-5411.2025.04.003.
6
Single-Centre Experience with the Balloon-Expandable Myval Transcatheter Aortic Valve System with the First 200 Patients: 30-Day and 1-Year Follow-Up.使用球囊扩张式Myval经导管主动脉瓣系统治疗首批200例患者的单中心经验：30天和1年随访
J Clin Med. 2025 Mar 28;14(7):2323. doi: 10.3390/jcm14072323.
7
Benefits of prophylactic veno-arterial extracorporeal membrane oxygenation for high-risk cardiac interventions.预防性静脉-动脉体外膜肺氧合用于高风险心脏介入治疗的益处。
BMC Surg. 2025 Mar 21;25(1):107. doi: 10.1186/s12893-025-02835-7.
8
Ferric carboxymaltose in reducing blood transfusions and infections after cardiac surgery.羧基麦芽糖铁在减少心脏手术后输血及感染方面的作用
JTCVS Open. 2024 Sep 19;22:332-344. doi: 10.1016/j.xjon.2024.09.009. eCollection 2024 Dec.
9
Implementing and evaluating shared decision-making before transcatheter aortic valve implantation with a dedicated pathway and questionnaire.通过专用路径和问卷在经导管主动脉瓣植入术前实施和评估共同决策。
Eur Heart J Open. 2024 Nov 4;4(6):oeae095. doi: 10.1093/ehjopen/oeae095. eCollection 2024 Nov.
10
Outcomes of Valve-in-Valve (VIV) Transcatheter Aortic Valve Replacement (TAVR) after Surgical Aortic Valve Replacement with Sutureless Surgical Aortic Valve Prostheses Perceval™: A Systematic Review of Published Cases.使用无缝合式外科主动脉瓣假体Perceval™进行外科主动脉瓣置换术后的瓣中瓣（VIV）经导管主动脉瓣置换术（TAVR）的结果：已发表病例的系统评价
J Clin Med. 2024 Aug 30;13(17):5164. doi: 10.3390/jcm13175164.